• Home
  • About
    • About Artemis
    • Leadership
  • Science
  • Pipeline
  • Publications
  • News
  • Contact Us

Artemis Therapeutics Announces $1 Million AI Technology Licensing Agreement with Rakovina Therapeutics

by Vanessa Ooms | Nov 10, 2026 | Company News & Press Releases

Download PDF Exclusive worldwide licence for DNA-damage response oncology drug discovery provides commercial validation of Artemis.AI™ platform and establishes framework for potential therapeutic co-development Vancouver, BC — Nov. 10, 2026 — Artemis Therapeutics Inc....

Artemis Therapeutics Announces Advisory Board of Leading Experts in AI, Drug Discovery, Clinical Oncology, Biotechnology and Capital Markets

by Vanessa Ooms | Oct 27, 2026 | Company News & Press Releases

Download PDF Artemis Therapeutics Announces Advisory Board of Leading Experts in AI, Drug Discovery, Clinical Oncology, Biotechnology and Capital Markets Distinguished advisory board brings together internationally recognized leaders to support the advancement of the...

AI and the Digital Disruption of Life Sciences: Dr. Cherkasov Presents at Princess Margaret

by Vanessa Ooms | Oct 8, 2026 | Lectures & Presentations

Dr. Artem Cherkasov, Co-Founder and President of Artemis Therapeutics, delivered an invited lecture titled “Digital Disruption of Life Sciences with Artificial Intelligence” as part of the Princess Margaret Distinguished Speaker Seminar Series at the University Health...

From Prompt to Patient: Dr. Cherkasov Joins EuroQSAR 2026 Roundtable

by Vanessa Ooms | Oct 1, 2026 | Lectures & Presentations

Dr. Artem Cherkasov, Co-Founder and President of Artemis Therapeutics, participated as an invited panel member at the 25th EuroQSAR Symposium, held in Perugia, Italy, from September 27 to October 1, 2026. Dr. Cherkasov joined the roundtable discussion titled “From...

Navigating the Chemical Universe: Artemis Co-Founder Presents at Cedars-Sinai

by Vanessa Ooms | Sep 3, 2026 | Lectures & Presentations

Dr. Artem Cherkasov, Co-Founder and President of Artemis Therapeutics, delivered an invited lecture titled “AI Navigation of Chemical Universe for Therapeutic Candidates” at the Cedars-Sinai Translational Research Institute in Los Angeles, California, on September 3,...
« Older Entries

Recent Posts

  • Artemis Therapeutics Announces $1 Million AI Technology Licensing Agreement with Rakovina Therapeutics
  • Artemis Therapeutics Announces Advisory Board of Leading Experts in AI, Drug Discovery, Clinical Oncology, Biotechnology and Capital Markets
  • AI and the Digital Disruption of Life Sciences: Dr. Cherkasov Presents at Princess Margaret
  • From Prompt to Patient: Dr. Cherkasov Joins EuroQSAR 2026 Roundtable
  • Navigating the Chemical Universe: Artemis Co-Founder Presents at Cedars-Sinai

COMPANY

About Artemis

Leadership

Advisory Board

Contact

TECHNOLOGY

Science

Pipeline

Publications

INVESTORS

News Releases

©2026 Artemis Therapeutics Inc. All rights reserved  | Privacy Policy  | Terms of Use | Site by Vanooms Media